FluidCloud gets $8.1M to reverse-engineer cloud environments and unlock true multicloud agility - SiliconANGLE ...

As organizations increasingly embrace the dynamic and scalable nature of multi-cloud environments to drive innovation and ...

Bitdefender Recognized for a Third Consecutive Year for Its Ability to Execute and Completeness of Vision Bitdefender is proud to announce that we have been named the only Visionary in the 2025 ...

In the Phase III CARES trials, anselamimab did not meet the primary endpoint for advanced-stage AL amyloidosis, but a prespecified subgroup analysis revealed meaningful improvements in survival and ...

Topline results were announced from a phase 3 study evaluating secukinumab in adults with newly diagnosed or relapsing giant cell arteritis (GCA). Secukinumab is an interleukin-17A antagonist ...